Lupica C R, Dunwiddie T V
Department of Pharmacology, University of Colorado Health Sciences Center, Denver 80262.
Synapse. 1991 Aug;8(4):237-48. doi: 10.1002/syn.890080402.
Previous studies have suggested that opioid receptor activation in the hippocampus increases pyramidal neuron excitability by reducing GABAergic inhibition. This hypothesis has received support with regard to mu-receptor agonists but has not been adequately tested with selective delta-receptor agonists. In the present investigation we compared the effects of the selective mu-opioid receptor agonist [Tyr-(D-Ala)-Gly-(N-Me-Phe)-Gly-ol]-enkephalin (DAGO) and the delta-receptor agonist [D-Pen2,D-Pen5]-enkephalin (DPDPE) to those of bicuculline methiodide (BMI) on extracellularly recorded feedforward (FFW) and recurrent (feedback; FB) inhibition. It was discovered that the control population spike response, evoked by Schaffer collateral/commissural axon stimulation, increased in response to DAGO, DPDPE, and BMI, while the secondary or test response increased only in the presence of DAGO and BMI. The resulting hypothesis that delta-opioid receptor activation facilitates synaptically evoked responses independently of a reduction of inhibition was investigated by examining the effect of DPDPE on the field EPSP response recorded in stratum radiatum of CA1, or postsynaptically on a burst response activated through antidromic stimulation of pyramidal neurons in low calcium medium. delta-Opioid receptor activation had no effect on either the field EPSP response or the burst response, suggesting that neither synaptic transmission nor postsynaptic excitability were augmented. Finally, the possibility that DPDPE acts to enhance pyramidal cell excitability independently of GABAergic transmission was further investigated by examining responses to both mu- and delta-opioid agonists following treatment with BMI (30 microM). Responses to DPDPE and DAGO were completely blocked by this treatment, supporting the involvement of a GABAergic circuit in the actions of these enkephalins. These results suggest that the delta-opioid receptor agonist DPDPE may mediate a reduction in GABAergic inhibition which is not detectable using paired stimulation techniques designed to examine FFW and FB inhibition in the hippocampal slice.
以往的研究表明,海马体中的阿片受体激活通过减少γ-氨基丁酸(GABA)能抑制作用来增加锥体神经元的兴奋性。这一假说在μ-受体激动剂方面得到了支持,但尚未用选择性δ-受体激动剂进行充分验证。在本研究中,我们比较了选择性μ-阿片受体激动剂[酪氨酸-(D-丙氨酸)-甘氨酸-(N-甲基苯丙氨酸)-甘氨酸-醇]-脑啡肽(DAGO)和δ-受体激动剂[D-青霉胺2,D-青霉胺5]-脑啡肽(DPDPE)与甲磺酸荷包牡丹碱(BMI)对细胞外记录的前馈(FFW)和反馈(FB)抑制作用的影响。结果发现,由Schaffer侧支/联合轴突刺激诱发的对照群体峰电位反应,在DAGO、DPDPE和BMI作用下增强,而次级或测试反应仅在DAGO和BMI存在时增强。通过研究DPDPE对CA1层辐射层记录的场兴奋性突触后电位(fEPSP)反应的影响,或在低钙培养基中对通过锥体神经元逆向刺激激活的爆发反应的突触后影响,来探讨δ-阿片受体激活是否独立于抑制作用的降低而促进突触诱发反应这一假说。δ-阿片受体激活对场兴奋性突触后电位反应或爆发反应均无影响,这表明突触传递和突触后兴奋性均未增强。最后,通过研究在BMI(30μM)处理后对μ-和δ-阿片激动剂的反应,进一步探讨了DPDPE是否独立于GABA能传递而增强锥体细胞兴奋性的可能性。该处理完全阻断了对DPDPE和DAGO的反应,支持了GABA能回路参与这些脑啡肽作用的观点。这些结果表明,δ-阿片受体激动剂DPDPE可能介导了GABA能抑制作用的降低,而使用旨在检测海马切片中前馈和反馈抑制的配对刺激技术无法检测到这种降低。